First human test of experimental pain pill begins
NCT ID NCT06636500
Summary
This early-stage study tested a new oral drug called CG001419, which is being developed for pain management. It involved 72 healthy volunteers to check if the drug is safe and how the body processes it, including whether taking it with food makes a difference. The main goal was to find the right dose for future studies in people with pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.